X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1755) 1755
Book Review (498) 498
Publication (234) 234
Book Chapter (24) 24
Conference Proceeding (9) 9
Book / eBook (7) 7
Newsletter (6) 6
Magazine Article (5) 5
Data Set (2) 2
Newspaper Article (2) 2
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1560) 1560
humans (1132) 1132
animals (808) 808
coronavirus (634) 634
viruses (433) 433
virology (426) 426
health aspects (393) 393
female (371) 371
infectious diseases (363) 363
male (356) 356
severe acute respiratory syndrome (347) 347
microbiology (295) 295
immunology (273) 273
infection (262) 262
mice (248) 248
sars (232) 232
adult (224) 224
acute respiratory syndrome (223) 223
virus diseases (219) 219
coronavirus infections - virology (216) 216
research (212) 212
infections (202) 202
middle aged (185) 185
analysis (180) 180
virus (180) 180
antiviral agents - pharmacology (179) 179
identification (171) 171
pneumonia (169) 169
antiviral agents - therapeutic use (168) 168
pharmacology & pharmacy (160) 160
proteins (156) 156
severe acute respiratory syndrome - virology (155) 155
cell line (144) 144
coronavirus infections - drug therapy (143) 143
mers-cov (143) 143
coronavirus infections - epidemiology (142) 142
replication (142) 142
influenza (140) 140
respiratory syndrome coronavirus (140) 140
antiviral agents (139) 139
spike protein (139) 139
hong-kong (138) 138
respiratory diseases (136) 136
outbreak (134) 134
sars coronavirus (132) 132
severe acute respiratory syndrome - drug therapy (131) 131
veterinary sciences (131) 131
aged (128) 128
biochemistry & molecular biology (127) 127
article (125) 125
severe acute respiratory syndrome - epidemiology (122) 122
epidemiology (115) 115
research article (114) 114
abridged index medicus (113) 113
sars-cov (112) 112
disease (111) 111
cercopithecus aethiops (109) 109
diagnosis (109) 109
respiratory system (109) 109
disease models, animal (104) 104
molecular sequence data (103) 103
mortality (103) 103
sars virus - genetics (103) 103
risk factors (102) 102
pathogenesis (101) 101
respiratory tract infections - virology (101) 101
coronavirus infections - diagnosis (98) 98
saudi-arabia (97) 97
disease outbreaks (96) 96
medicine, general & internal (96) 96
severe acute respiratory syndrome - diagnosis (96) 96
interferon (95) 95
middle east respiratory syndrome coronavirus (95) 95
coronavirus infections - therapy (94) 94
infectious disease (94) 94
vaccines (94) 94
vero cells (93) 93
viral infections (93) 93
medicine (92) 92
child (91) 91
sars virus - immunology (91) 91
adolescent (90) 90
care and treatment (90) 90
coronavirus infections - immunology (90) 90
respiratory tract diseases (89) 89
epidemics (88) 88
antibodies (84) 84
cats (84) 84
cells (84) 84
severe acute respiratory syndrome - immunology (84) 84
virus replication - drug effects (84) 84
amino acid sequence (83) 83
severe acute respiratory syndrome - prevention & control (83) 83
severe acute respiratory syndrome - therapy (83) 83
virus replication (83) 83
medical research (82) 82
multidisciplinary sciences (81) 81
infant (80) 80
reverse transcriptase polymerase chain reaction (80) 80
child, preschool (79) 79
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1761) 1761
German (10) 10
Chinese (8) 8
French (8) 8
Japanese (2) 2
Polish (2) 2
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Internal Medicine, ISSN 0003-4819, 03/2014, Volume 160, Issue 6, pp. 389 - 397
Background: Since September 2012, 170 confirmed infections with Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health... 
HIGH-FREQUENCY OSCILLATION | MEDICINE, GENERAL & INTERNAL | REPLICATION | DISTRESS-SYNDROME | NITRIC-OXIDE | ACUTE LUNG INJURY | SARS | MERS-COV | CORTICOSTEROIDS | Community-Acquired Infections - therapy | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Respiratory Insufficiency - virology | Male | Adrenal Cortex Hormones - therapeutic use | Respiratory Tract Infections - therapy | Coronavirus Infections - epidemiology | Aged, 80 and over | Coronavirus Infections - complications | Adult | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Respiratory Tract Infections - virology | Cross Infection - virology | Community-Acquired Infections - virology | Saudi Arabia - epidemiology | Cross Infection - epidemiology | Length of Stay | Cross Infection - therapy | Intensive Care Units | Antiviral Agents - therapeutic use | Communicable Diseases, Emerging - therapy | Treatment Outcome | Communicable Diseases, Emerging - epidemiology | Respiratory Insufficiency - therapy | Respiration, Artificial | Syndrome | Immunoglobulins, Intravenous - therapeutic use | Coronavirus Infections - therapy | Aged | Respiratory Tract Infections - epidemiology | Communicable Diseases, Emerging - virology | Medical research | Care and treatment | Coronavirus infections | Mortality | Distribution | Medicine, Experimental | Research | Health care | Disease transmission | Kidney diseases | Blood platelets | Patients | Respiratory diseases | Index Medicus | Abridged Index Medicus
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 01/2017, Volume 17, Issue 1, pp. 62 - 62
textabstractBackground: The number of viral pathogens associated with pediatric acute respiratory tract infection (ARI) has grown since the introduction of... 
Respiratory tract infections | Respiratory viruses | Co-infection | Respiratory Syncytial Virus | Child | SYNCYTIAL VIRUS BRONCHIOLITIS | INFECTIOUS DISEASES | LOAD | TRACT INFECTIONS | HOSPITALIZED CHILDREN | PROSPECTIVE COHORT | CLINICAL IMPACT | HUMAN METAPNEUMOVIRUS | INFANTS | RHINOVIRUS INFECTION | SEVERITY | Adenovirus Infections, Human - therapy | Multivariate Analysis | Virus Diseases - epidemiology | Pneumonia - therapy | Prospective Studies | Respiratory Syncytial Virus Infections - epidemiology | Viruses - genetics | Humans | Netherlands - epidemiology | Infant | Male | Virus Diseases - virology | Picornaviridae Infections - virology | Adenovirus Infections, Human - epidemiology | Anti-Bacterial Agents - therapeutic use | Respiratory Tract Infections - therapy | Coronavirus Infections - epidemiology | Picornaviridae Infections - epidemiology | Female | Influenza, Human - virology | Respiratory Tract Infections - virology | Seasons | Influenza, Human - therapy | Respiratory Syncytial Virus Infections - virology | Real-Time Polymerase Chain Reaction | Length of Stay | Severity of Illness Index | Pneumonia - epidemiology | Virus Diseases - therapy | Influenza, Human - epidemiology | Coinfection - epidemiology | Reverse Transcriptase Polymerase Chain Reaction | Coinfection - virology | Oxygen Inhalation Therapy | Pneumonia - virology | Fever | Coronavirus Infections - virology | Coronavirus Infections - therapy | Picornaviridae Infections - therapy | Respiratory Syncytial Virus Infections - therapy | Respiratory Tract Infections - epidemiology | Nebulizers and Vaporizers | Adenovirus Infections, Human - virology | Virus diseases | Care and treatment | Diagnosis | Pediatric respiratory diseases | Pediatrics | Pathogens | Clinical trials | Viruses | Infections | Patients | Medical ethics | Asthma | Whooping cough | Polymerase chain reaction | Respiratory syncytial virus | Consent | Data collection | Hypoxia | Viral infections | Index Medicus
Journal Article
Critical Care Medicine, ISSN 0090-3493, 10/2017, Volume 45, Issue 10, pp. 1683 - 1695
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2015, Volume 112, Issue 28, pp. 8738 - 8743
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2018, Volume 13, Issue 11, pp. e0206831 - e0206831
Background Middle East Respiratory Syndrome Coronavirus (MERS-CoV) leads to healthcare-associated transmission to patients and healthcare workers with... 
IMMUNITY | PANDEMIC INFLUENZA | MULTIDISCIPLINARY SCIENCES | DISEASE | HEMODIALYSIS-PATIENTS | SYNDROME CORONAVIRUS INFECTION | OUTCOMES | CLINICAL-COURSE | OUTBREAK | SAUDI-ARABIA | NONPREGNANT WOMEN | Humans | Middle Aged | Male | Occupational Diseases - diagnosis | Karnofsky Performance Status | Coronavirus Infections - epidemiology | Disease Outbreaks | Adult | Female | Retrospective Studies | Cross Infection - virology | Saudi Arabia - epidemiology | Cross Infection - epidemiology | Cross Infection - therapy | Hospital Mortality | Comorbidity | Coronavirus Infections - diagnosis | Survival Rate | Extracorporeal Membrane Oxygenation - statistics & numerical data | Health Personnel - statistics & numerical data | Critical Illness - epidemiology | Occupational Diseases - therapy | Occupational Diseases - virology | Coronavirus Infections - virology | Coronavirus Infections - therapy | Middle East Respiratory Syndrome Coronavirus - isolation & purification | Critical Illness - therapy | Cross Infection - diagnosis | Occupational Diseases - epidemiology | Medical personnel | Disease transmission | Research | Health risk assessment | Health aspects | Analysis | Health care | Health sciences | Pneumonia | Intensive care | Renal function | Pandemics | Demography | Hemodialysis | Impairment | Critical care | Outbreaks | Infections | Demographics | Medical research | Risk groups | Severe acute respiratory syndrome | Health care policy | Patients | Quality of life | Medicine | Infectious diseases | Hospitals | Womens health | Workers | Influenza | Respiratory diseases | Index Medicus | Surveys
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 09/2016, Volume 22, Issue 9, pp. 1554 - 1561
We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by... 
ANTIBODIES | INFECTIOUS DISEASES | THERAPY | CORONAVIRUS INFECTION | WORKERS | SPIKE PROTEIN | INFLUENZA | SARS | SERUM | MODEL | IMMUNOLOGY | PNEUMONIA | Immunotherapy - methods | Enzyme-Linked Immunosorbent Assay | Humans | Plasma - immunology | Neutralization Tests | Reverse Transcriptase Polymerase Chain Reaction | Coronavirus Infections - immunology | Middle East Respiratory Syndrome Coronavirus - immunology | Saudi Arabia | Antibodies, Neutralizing - immunology | Coronavirus Infections - virology | Immunoglobulin G - immunology | Middle East Respiratory Syndrome Coronavirus - genetics | Coronavirus Infections - therapy | Health Personnel | RNA, Viral | Antibodies, Viral - immunology | Usage | Immunotherapy | Mortality | Research | Health aspects | Risk factors | Viral antibodies | Antibodies | Enzyme-linked immunosorbent assay | Index Medicus | viruses | intensive care | convalescent phase | IFA | microneutralization | Middle East respiratory syndrome coronavirus | neutralizing antibodies | MERS-CoV | Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia | Middle East respiratory syndrome | respiratory infections | antibody titers | feasibility study | immunotherapy | convalescent-phase plasma | indirect immunofluorescent antibody assay | seroreactive | MERS | humans | convalescent plasma | ELISA | high-titer convalescent plasma
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 02/2015, Volume 60, Issue 4, pp. 586 - 595
Background. Patients infected with influenza A(H7N9) virus present with acute lung injury (ALI) that is due to severe pneumonia and systemic inflammation. It... 
H7N9 | complement inhibition | lung injury | African green monkey | anti-C5a antibody | INFECTIOUS DISEASES | COMPLEMENT ACTIVATION | INFLUENZA | INJURY | C1-INHIBITOR | MICROBIOLOGY | IMMUNOLOGY | ACUTE RESPIRATORY SYNDROME | C5A | IMMUNE | INHIBITION | CORONAVIRUS INFECTION | ANAPHYLATOXINS | Influenza, Human - pathology | Complement Activation | Acute Lung Injury - therapy | Humans | Viral Load | Systemic Inflammatory Response Syndrome - therapy | Lung - virology | Antibodies, Neutralizing - therapeutic use | Influenza A Virus, H7N9 Subtype - pathogenicity | Influenza, Human - virology | Influenza, Human - therapy | Macrophages, Alveolar - immunology | Disease Models, Animal | Orthomyxoviridae Infections - therapy | Lung - pathology | Cercopithecus aethiops - virology | Influenza A Virus, H7N9 Subtype - isolation & purification | Pneumonia, Viral - therapy | Orthomyxoviridae Infections - pathology | Pneumonia, Viral - pathology | Neutrophils - immunology | Treatment Outcome | Body Temperature | Acute Lung Injury - pathology | Pneumonia, Viral - immunology | Complement C5a - antagonists & inhibitors | Systemic Inflammatory Response Syndrome - pathology | Animals | Acute Lung Injury - immunology | Acute Lung Injury - virology | Complement C5a - immunology | Orthomyxoviridae Infections - virology | Pneumonia, Viral - virology | Orthomyxoviridae Infections - immunology | Influenza, Human - immunology | Systemic Inflammatory Response Syndrome - virology | Viral antibodies | Complications and side effects | Care and treatment | Influenza | Patient outcomes | Lung diseases | Cercopithecus aethiops | Physiological aspects | Antibodies | Dosage and administration | Research | Risk factors | Immunoglobulins | Pathogenesis | Medical treatment | Animal diseases | Monkeys & apes | Index Medicus
Journal Article
Journal of Virology, ISSN 0022-538X, 09/2018, Volume 92, Issue 18
Journal Article